Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluating serum free light chain ratio as a biomarker in multiple myeloma.
Akhlaghi T, Maclachlan K, Korde N, Mailankody S, Lesokhin A, Hassoun H, Lu SX, Patel D, Shah U, Tan C, Derkach A, Lahoud O, Landau HJ, Shah GL, Scordo M, Chung DJ, Giralt SA, Usmani SZ, Landgren O, Hultcrantz M. Akhlaghi T, et al. Among authors: derkach a. Haematologica. 2024 Oct 3. doi: 10.3324/haematol.2024.285531. Online ahead of print. Haematologica. 2024. PMID: 39363855 Free article.
Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: a prospective observational cohort study.
Korde N, Tavitian E, Mastey D, Lengfellner J, Hevroni G, Zarski A, Salcedo M, Mailankody S, Hassoun H, Smith EL, Hultcrantz M, Shah U, Tan C, Diamond B, Shah G, Scordo M, Lahoud O, Chung DJ, Landau H, Giralt S, Derkach A, Atkinson TM, Sabbatini P, König F, Usmani SZ, Landgren O, Lesokhin AM. Korde N, et al. Among authors: derkach a. EClinicalMedicine. 2023 Feb 27;57:101854. doi: 10.1016/j.eclinm.2023.101854. eCollection 2023 Mar. EClinicalMedicine. 2023. PMID: 36895800 Free PMC article.
E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial.
Bewersdorf JP, Stahl M, Taylor J, Mi X, Chandhok NS, Watts J, Derkach A, Wysocki M, Lu SX, Bourcier J, Hogg SJ, Rahman J, Chaudhry S, Totiger TM, Abdel-Wahab O, Stein EM. Bewersdorf JP, et al. Among authors: derkach a. Leukemia. 2023 Dec;37(12):2512-2516. doi: 10.1038/s41375-023-02050-4. Epub 2023 Oct 9. Leukemia. 2023. PMID: 37814121 Free PMC article. Clinical Trial. No abstract available.
Wearable sensor-based performance status assessment in cancer: A pilot multicenter study from the Alliance for Clinical Trials in Oncology (A19_Pilot2).
Wood WA, Dilip D, Derkach A, Grover NS, Elemento O, Levine R, Thanarajasingam G, Batsis JA, Bailey C, Kannappan A, Devine SM, Artz AS, Ligibel JA, Basch E, Kent E, Glass J. Wood WA, et al. Among authors: derkach a. PLOS Digit Health. 2023 Jan 26;2(1):e0000178. doi: 10.1371/journal.pdig.0000178. eCollection 2023 Jan. PLOS Digit Health. 2023. PMID: 36812616 Free PMC article.
Defining 2 Biologically and Clinically Distinct Groups in Acute Leukemia with a Mixed Phenotype.
Galera P, Dilip D, Derkach A, Chan A, Zhang Y, Persaud S, Mishra T, Kramer K, Kathpalia M, Liu Y, Famulare CA, Gao Q, Mata DA, Arcila ME, Geyer MB, Stein EM, Dogan A, Roshal M, Levine RL, Glass JL, Xiao W. Galera P, et al. Among authors: derkach a. Blood. 2025 Jan 15:blood.2024026273. doi: 10.1182/blood.2024026273. Online ahead of print. Blood. 2025. PMID: 39813682
HMA/VEN treatment modifications and associated outcomes in IDH-mutant AML.
Chin KK, Derkach A, Famulare C, Gupta GK, Borge PD, Geyer MB, Goldberg AD, Haque T, Park JH, Roeker LE, Tallman MS, Stahl M, Stein EM. Chin KK, et al. Among authors: derkach a. Leuk Lymphoma. 2025 Feb;66(2):270-278. doi: 10.1080/10428194.2024.2411436. Epub 2024 Oct 14. Leuk Lymphoma. 2025. PMID: 39397429
101 results